StocksFundsScreenerSectorsWatchlists
VERU

VERU - Veru Inc Stock Price, Fair Value and News

1.31USD-0.11 (-7.75%)Delayed

Market Summary

VERU
USD1.31-0.11
Delayed
-7.75%

VERU Stock Price

View Fullscreen

VERU RSI Chart

VERU Valuation

Market Cap

191.8M

Price/Earnings (Trailing)

-2.97

Price/Sales (Trailing)

12.04

EV/EBITDA

-2.98

Price/Free Cashflow

-3.19

VERU Price/Sales (Trailing)

VERU Profitability

EBT Margin

-402.05%

Return on Equity

-125.04%

Return on Assets

-80.09%

Free Cashflow Yield

-31.38%

VERU Fundamentals

VERU Revenue

Revenue (TTM)

15.9M

Rev. Growth (Yr)

-14.64%

Rev. Growth (Qtr)

-44.57%

VERU Earnings

Earnings (TTM)

-64.5M

Earnings Growth (Yr)

77.54%

Earnings Growth (Qtr)

23.33%

Breaking Down VERU Revenue

Last 7 days

-14.5%

Last 30 days

120.3%

Last 90 days

251.4%

Trailing 12 Months

8.3%

How does VERU drawdown profile look like?

VERU Financial Health

Current Ratio

3.21

Debt/Equity

0.03

Debt/Cashflow

-34.95

VERU Investor Care

Dividend Yield

16.03%

Dividend/Share (TTM)

0.21

Shares Dilution (1Y)

77.27%

Diluted EPS (TTM)

-0.74

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202321.3M15.0M16.3M15.9M
202260.5M52.4M39.4M27.7M
202150.0M57.4M61.3M60.8M
202039.0M39.6M42.6M46.6M
201924.1M28.3M31.8M36.0M
201813.2M14.4M15.9M19.6M
201714.8M13.5M13.7M13.0M
201628.0M25.7M22.1M17.1M
201531.1M31.0M32.6M34.2M
201423.1M23.7M24.5M24.5M
201338.0M36.6M31.5M28.2M
201227.1M32.2M35.0M36.3M
201120.4M19.5M18.6M23.5M
2010024.9M22.2M21.3M
20090027.5M0

Tracking the Latest Insider Buys and Sells of Veru Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Aug 15, 2022
eisenberger mario
acquired
156,950
1.5695
100,000
-
Aug 15, 2022
eisenberger mario
sold
-2,003,550
20.0355
-100,000
-
Aug 17, 2021
lu lucy
bought
32,542
6.7796
4,800
-
Jun 16, 2021
fisch harry
sold
-835,300
8.353
-100,000
-
Mar 10, 2021
hyun grace
bought
49,315
14.09
3,500
-
Feb 12, 2021
steiner mitchell shuster
sold
-417,688
20.8844
-20,000
president and ceo
Dec 16, 2020
steiner mitchell shuster
sold
-2,421,620
9.6865
-250,000
president and ceo
Dec 16, 2020
barnette k gary
sold
-1,064,510
10.6451
-100,000
chief scientific officer
Aug 26, 2020
fisch harry
bought
13,799
2.7599
5,000
-
Aug 24, 2020
greco michele
bought
13,233
2.6466
5,000
cao and cfo

1–10 of 50

Which funds bought or sold VERU recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 18, 2024
McGlone Suttner Wealth Management, Inc.
sold off
-100
-72.00
-
-%
Apr 18, 2024
SeaCrest Wealth Management, LLC
new
-
20,303
20,303
-%
Apr 16, 2024
Moisand Fitzgerald Tamayo, LLC
sold off
-100
-1,008
-
-%
Apr 16, 2024
Weaver Consulting Group
new
-
15,604
15,604
0.01%
Apr 16, 2024
180 WEALTH ADVISORS, LLC
new
-
119,542
119,542
0.02%
Apr 15, 2024
Sound Income Strategies, LLC
unchanged
-
-73.00
2,574
-%
Apr 15, 2024
KINGSWOOD WEALTH ADVISORS, LLC
added
3.33
82.00
17,362
-%
Apr 11, 2024
First Affirmative Financial Network
new
-
8,171
8,171
0.01%
Apr 05, 2024
CWM, LLC
unchanged
-
-1,000
-
-%
Mar 22, 2024
PNC FINANCIAL SERVICES GROUP, INC.
unchanged
-
5.00
3,600
-%

1–10 of 41

Are Funds Buying or Selling VERU?

Are funds buying VERU calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own VERU
No. of Funds

Unveiling Veru Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
perceptive advisors llc
3.8%
5,584,699
SC 13G/A
Feb 06, 2024
frost phillip md et al
3.5%
5,100,253
SC 13G/A
Dec 26, 2023
adage capital partners gp, l.l.c.
9.50%
13,722,222
SC 13G
Dec 08, 2023
morgan stanley
4.2%
3,756,588
SC 13G/A
Sep 28, 2023
frost phillip md et al
5.7%
5,100,253
SC 13G/A
Jun 08, 2023
blackrock inc.
4.98%
4,421,516
SC 13G/A
Apr 19, 2023
frost phillip md et al
6.1%
5,000,253
SC 13G
Feb 14, 2023
perceptive advisors llc
9.7%
7,858,011
SC 13G
Feb 14, 2023
tang capital partners lp
0.0%
0
SC 13G/A
Feb 10, 2023
blackrock inc.
5.8%
4,654,892
SC 13G/A

Recent SEC filings of Veru Inc

View All Filings
Date Filed Form Type Document
Apr 01, 2024
DEFA14A
DEFA14A
Apr 01, 2024
10-Q
Quarterly Report
Apr 01, 2024
10-K/A
Annual Report
Mar 22, 2024
DEFA14A
DEFA14A
Feb 28, 2024
8-K
Current Report
Feb 15, 2024
NT 10-Q
NT 10-Q
Feb 15, 2024
8-K
Current Report
Feb 14, 2024
SC 13G/A
Major Ownership Report
Feb 08, 2024
8-K
Current Report
Feb 06, 2024
SC 13G/A
Major Ownership Report

Peers (Alternatives to Veru Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
38.7B
6.8B
-1.66% -28.18%
-8.22
5.66
-64.45% -156.37%
22.4B
152.6K
-0.77% 465779.94%
-2.4K
146.8K
- -9.98%
18.2B
1.8B
-2.46% -28.84%
-41.3
9.94
76.23% 61.08%
16.7B
2.4B
4.57% -8.46%
99.75
6.91
15.42% 18.43%
11.8B
3.7B
-10.11% -29.11%
19.67
3.18
8.87% 75.42%
MID-CAP
5.7B
396.6M
-14.37% -42.33%
-10.84
14.45
425.83% 18.94%
4.4B
-
-13.59% 50.21%
-6.66
60.35
54.84% -34.79%
3.2B
270.6M
-13.81% -4.67%
-13.46
11.9
440.80% -27.84%
2.8B
726.4M
-9.91% -15.82%
-45.19
3.81
40.45% 71.62%
2.8B
240.7M
-20.67% -25.33%
-9.33
12.18
-1.03% -92.09%
SMALL-CAP
1.8B
398.2M
-10.64% -8.42%
24.94
4.47
85.90% -14.05%
558.4M
983.7M
-17.39% -51.52%
-1.02
0.57
-50.36% 17.16%
409.4M
881.7K
-0.38% 387.14%
-9.18
466.16
-77.61% -5.33%
226.2M
4.9M
-10.29% -2.81%
-1.67
46.49
-54.97% 51.71%
6.0M
2.1M
59.81% 33.59%
-0.22
2.14
-13.45% 66.37%

Veru Inc News

Latest updates
Yahoo Finance17 Apr 202404:00 pm
TradingView16 Apr 202405:34 pm
MarketBeat15 Apr 202412:31 pm

Veru Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue-44.6%2,140,7263,862,0123,341,1856,585,9672,507,7942,588,6319,602,19513,028,39414,135,13215,646,46017,655,59213,340,48714,616,98911,749,18610,321,7549,943,10410,578,0168,728,4039,727,0606,976,1156,371,809
Gross Profit-25.4%1,150,4521,541,1801,230,6184,092,075702,055505,4057,068,62311,175,27811,842,08212,309,17813,873,11210,908,30010,836,6339,562,1476,519,1187,436,4987,269,0955,832,7336,571,1584,608,8514,644,080
Operating Expenses-25.6%9,951,48113,378,88613,828,08743,510,84136,290,21445,177,94128,892,39822,940,24216,804,36714,180,40416,744,97612,379,71010,059,6346,731,9187,911,9707,736,1769,053,4887,290,3088,413,1606,733,4415,655,807
  S&GA Expenses22.5%8,301,4316,774,55910,902,91612,834,49417,545,86518,290,51510,761,4867,401,1386,723,2065,924,8125,556,7304,806,8974,381,8803,463,4263,475,4743,805,9163,753,5143,685,0063,547,0463,822,8543,293,984
  R&D Expenses-75.0%1,650,0506,604,3272,925,17122,864,63318,744,34926,890,42618,133,41215,541,10410,081,1618,255,59211,188,2467,572,8135,677,7543,268,4924,436,4963,930,2605,299,9743,605,3024,866,1142,910,5872,361,823
EBITDA Margin29.4%-3.90-5.52-8.00-6.35-3.96-2.01-0.81-0.42-0.230.150.020.07---------
Interest Expenses-20.4%164,957207,201648,917697,693873,230812,3211,185,0931,212,7021,158,6821,157,7951,287,5251,251,5511,189,1831,145,3431,169,6921,164,9621,141,4251,078,0851,091,2761,258,2721,278,423
Income Taxes-113.0%-72,439557,49257,551-66,559-68,27811,589137,603-27,450114,655-356,067-2,873,06321,69078,302-1,109,060240,502-133,140-76,743-421,140-45825,16792,498
Earnings Before Taxes18.4%-8,348,420-10,236,195-6,602,630-38,859,465-36,910,457-41,011,019-22,057,973-14,205,280-6,265,351-4,650,547-5,565,929-2,824,29117,306,003-12,941,605-2,784,878-943,649-3,381,844-3,481,597-2,774,534-4,008,868-2,056,300
EBT Margin29.2%-4.02-5.68-8.21-6.52-4.12-2.12-0.90-0.51-0.320.07-0.07-0.02---------
Net Income23.3%-8,275,981-10,793,687-6,660,181-38,792,906-36,842,179-41,022,608-22,195,576-14,177,830-6,380,006-4,294,480-2,692,866-2,845,98117,227,701-11,832,545-3,025,380-810,509-3,305,101-3,060,457-2,774,076-4,034,035-2,148,798
Net Income Margin29.1%-4.05-5.71-8.21-6.52-4.12-2.13-0.90-0.46-0.270.120.00-0.01---------
Free Cashflow35.8%-6,233,263-9,705,334-18,457,329-25,697,258-34,819,593-21,027,305-14,118,848-4,131,902-8,960,001-1,028,701-12,976,589-2,594,438---------
Balance Sheet
(In Thousands)
Balance Sheet
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets59.2%80,56750,59662,22170,254103,782136,126160,577172,825172,165178,147180,073181,15172,78851,54465,18855,87654,53653,62953,84151,01252,335
  Current Assets126.9%53,34523,50634,68543,28873,009104,769128,361140,461145,707151,753154,406156,05247,56727,01526,85917,46016,81616,80717,14314,14315,373
    Cash Equivalents-------------------8,0395,8978,979
  Inventory3.2%6,9126,6976,4907,6658,7338,6197,7236,4154,9005,5746,9467,7956,6666,7045,1946,0164,5953,6473,1312,9982,698
  Net PPE-5.6%1,5601,6531,4921,5201,4261,1861,0821,025869593392271288313315332336352315321362
  Goodwill0%6,8796,8796,8796,9006,9006,9006,8796,8796,8796,8796,8796,8796,8796,9006,8796,8796,8796,8796,8796,8796,879
Liabilities-11.7%28,96532,81340,80853,53854,68455,28743,71036,82724,16025,85325,10525,65524,04021,43223,90924,76224,89421,29619,10517,46815,453
  Current Liabilities-18.0%16,62520,27927,68639,26040,08041,43827,80921,18113,94115,76717,21218,86717,06314,72717,37316,82016,90914,02011,66311,2729,742
  Long Term Debt---------------------1,703
    LT Debt, Non Current---------------------1,703
Shareholder's Equity190.2%51,60217,78321,41316,71649,09980,839116,868135,998148,004152,294154,968155,49648,74830,11141,27931,11529,64332,33334,73633,54436,882
  Retained Earnings-2.5%-265,044-258,663-247,869-241,209-202,416-165,574-124,551-102,356-88,178-81,798-77,503-74,810-71,964-89,192-77,360-74,334-73,524-70,219-67,158-64,384-60,350
  Additional Paid-In Capital14.0%323,549283,895276,756265,466259,075253,974248,984245,920243,748241,659240,040237,876128,360126,972126,307113,159110,883110,268109,613105,667104,972
Accumulated Depreciation1.7%3,8543,788---3,642---------------
Shares Outstanding59.5%146,38191,78389,23782,57780,62380,50980,05580,05380,02379,97079,72972,718---------
Float----77,700---311,400---689,500---162,300---67,800-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations36.6%-6,020-9,492-18,431-25,555-34,534-20,878-14,022-3,946-8,657-806-12,834-2,589659-3413,339-2,416-2,510-955-527-2,496-1,506
  Share Based Compensation-27.3%3,4074,6854,5513,8384,8454,3262,9112,1251,8801,3631,9001,002785665685682614524468496417
Cashflow From Investing-100.0%-7875,974-141-285-1482,403-1852,198-222-142-4.9314,993-32.32-18.76-32.87-21.81-33.57-74.30--
Cashflow From Financing1646.0%36,9742,1185,1722,2681,55666715443.00204232-542108,3481,681-1,4329,517832412-7552,745-5856,726

VERU Income Statement

2023-09-30
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]  
Net revenues$ 16,296,958$ 39,354,352
Cost of sales8,731,0308,762,964
Gross profit7,565,92830,591,388
Operating expenses:  
Research and development51,202,21970,910,701
Selling, general and administrative48,057,83443,177,345
Provision for (recovery of) credit losses3,911,714(8,500)
Impairment of intangible assets3,900,000 
Total operating expenses107,071,767114,079,546
Gain on sale of ENTADFI® assets5,723,623 
Operating loss(93,782,216)(83,488,158)
Non-operating income (expenses):  
Interest expense(2,427,041)(4,368,798)
Change in fair value of derivative liabilities2,963,0003,557,000
Other income, net573,771495,735
Total non-operating income (expenses)1,109,730(316,063)
Loss before income taxes(92,672,486)(83,804,221)
Income tax expense480,206236,397
Net loss$ (93,152,692)$ (84,040,618)
Net loss per basic common share outstanding$ (1.10)$ (1.05)
Basic weighted average common shares outstanding84,973,38280,122,526
Net loss per diluted common share outstanding$ (1.10)$ (1.05)
Diluted weighted average common shares outstanding84,973,38280,122,526

VERU Balance Sheet

2023-09-30
CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2023
Sep. 30, 2022
Current assets:  
Cash and cash equivalents$ 9,625,494$ 80,190,675
Accounts receivable, net4,506,5083,550,895
Inventories, net6,697,1178,618,944
Prepaid research and development costs1,006,2529,677,020
Prepaid expenses and other current assets1,097,8511,964,373
Total current assets22,933,222104,001,907
Plant and equipment, net1,652,7321,185,766
Operating lease right-of-use asset4,332,4734,786,915
Deferred income taxes12,707,41912,965,985
Intangible assets, net5,9523,977,381
Goodwill6,878,9326,878,932
Other assets1,512,3611,561,564
Total assets50,023,091135,358,450
Current liabilities:  
Accounts payable12,931,17222,003,394
Accrued research and development costs31,6636,345,255
Accrued compensation990,6095,986,557
Accrued expenses and other current liabilities1,956,0752,249,995
Residual royalty agreement, short-term portion (Note 9)864,6231,169,095
Operating lease liability, short-term portion1,036,590957,085
Total current liabilities17,810,73238,711,381
Residual royalty agreement, long-term portion (Note 9)8,870,1369,656,441
Operating lease liability, long-term portion3,634,1144,093,667
Deferred income taxes 81,067
Other liabilities29,94818,577
Total liabilities30,344,93052,561,133
Commitments and contingencies (Note 13)
Stockholders' equity:  
Preferred stock, no shares issued and outstanding at September 30, 2023 and 2022, respectively
Common stock, par value $0.01 per share; 308,000,000 and 154,000,000 shares authorized, 93,966,402 and 82,692,598 shares issued and 91,782,698 and 80,508,894 shares outstanding at September 30, 2023 and 2022, respectively939,664826,926
Additional paid-in-capital283,894,830253,974,032
Accumulated other comprehensive loss(581,519)(581,519)
Accumulated deficit(256,768,209)(163,615,517)
Treasury stock, 2,183,704 shares, at cost(7,806,605)(7,806,605)
Total stockholders' equity19,678,16182,797,317
Total liabilities and stockholders' equity$ 50,023,091$ 135,358,450
VERU
Veru Inc., a biopharmaceutical company, focuses on developing medicines for the management of COVID-19, and breast and prostate cancers. Its commercial products comprise FC2 female condom/internal condom for the protection against unintended pregnancy and the transmission of sexually transmitted infections; and Entadfi, a capsule for the treatment of urinary tract symptoms. The company's drug candidates under development include Enobosarm, an oral selective androgen receptor agonist that is in phase III clinical trial for the treatment of AR+ ER+ HER2- metastatic breast cancer; Sabizabulin, which is phase 2b clinical trial for the treatment of AR+ ER+ HER2- metastatic breast cancer; and Enobosarm + abemaciclib combination therapy, which is in phase III clinical trial for the treatment of AR+ ER+ HER2- metastatic breast cancer. In addition, its drug candidate also comprise Sabizabulin, which is in Phase 3 clinical trial for the treatment of metastatic castration and androgen receptor targeting agent resistant prostate cancer; VERU-100, a GnRH antagonist peptide injection, which is in Phase II clinical trial for the treatment of advanced hormone sensitive prostate cancer; Zuclomiphene Citrate, which is in Phase 2b clinical trial for treating hot flashes; and Sabizabulin, an oral microtubule disruptor with dual antiviral and anti-inflammatory to severe COVID-19 patients at risk for acute respiratory distress syndrome. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.
 CEO
 WEBSITEverupharma.com
 INDUSTRYBiotechnology
 EMPLOYEES233

Veru Inc Frequently Asked Questions


What is the ticker symbol for Veru Inc? What does VERU stand for in stocks?

VERU is the stock ticker symbol of Veru Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Veru Inc (VERU)?

As of Fri Apr 19 2024, market cap of Veru Inc is 190.3 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of VERU stock?

You can check VERU's fair value in chart for subscribers.

What is the fair value of VERU stock?

You can check VERU's fair value in chart for subscribers. The fair value of Veru Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Veru Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for VERU so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Veru Inc a good stock to buy?

The fair value guage provides a quick view whether VERU is over valued or under valued. Whether Veru Inc is cheap or expensive depends on the assumptions which impact Veru Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for VERU.

What is Veru Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 19 2024, VERU's PE ratio (Price to Earnings) is -2.95 and Price to Sales (PS) ratio is 11.95. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. VERU PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Veru Inc's stock?

In the past 10 years, Veru Inc has provided -0.162 (multiply by 100 for percentage) rate of return.